IndiaTickerLatest filing: General Updates - Cohance Lifesciences Limited
ObservedCompany dossier
Cohance Lifesciences
NSE:COHANCE · ISIN INE03QK01018
- Close
- ₹431.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Cohance Lifesciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹307.2 Cr · PAT ₹83.3 Cr.
Exchange XBRLLatest ownership: promoter group 57.49% and public 42.51% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Cohance Lifesciences Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Cohance Lifesciences Limited
NSE · exchange filing
Observed
Source filing Cohance Lifesciences Ltd - 543064 - Allotment Of Equity Shares Pursuant To Exercise Of Stock Options And Grant Of Stock Options To Certain Eligible Employees Of The Company
BSE · exchange filing
Observed
Source filing Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Cohance Lifesciences Limited
NSE · conference call
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹307.2 Cr
- Profit after tax
- ₹83.3 Cr
- EPS
- ₹3.26
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 57.49%
- Public
- 42.51%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL